Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia

Australian and New Zealand Journal of Psychiatry

Volumn 31, Issue 1, 1997, Pages 27-35

  Hickie, Ian ^a   Lloyd, Andrew ^b   Dixon, Gavin ^b   Halliday, Glenda ^c   McRitchie, Deborah ^c   Scott, Elizabeth ^a   Mitchell, Philip ^b,d   Wakefield, Denis ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d PRINCE HENRY HOSPITAL   (Australia)

Author keywords

Dopamine; In situ hybridisation; Melancholia

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR;

ARTICLE; BRAIN TISSUE; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; MELANCHOLIA; MOLECULAR BIOLOGY;

EID: 0030946150     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679709073796     Document Type: Article

References (36)

1. Parker G, Hadzi-Pavlovic D, Boyce P et al. Classifying depression by mental state signs British Journal of Psychiatry 1990, 157.55-65.
2. Parker G, Hadzi-Pavlovic D, Wilhelm K et al. Defining melancholia: properties of a refined sign-based measure. British Journal of Psychiatry 1994; 164:316-326.
3. Hickie I, Hickie C, Scott E, Wilhelm K. Magnetic resonance imaging in primary and secondary depression. In: Parker G, Hadzi-Pavlovic D, eds. Melancholia: a disorder of movement and mood. New York: Cambridge University Press, 1996:252-266.
4. Mayberg HS. Frontal lobe dysfunction in secondary depression. Journal of Neuropsychiatry and Clinical Neurosciences 1994, 6:428-442.
5. Cummings JL, Benson DF. Psychological dysfunction accompanying dementias and subcortical dementias. Annual Reviews in Medicine 1988; 39:53-61.
6. Cummings JL. Depression and Parkinson's disease: a review. American Journal of Psychiatry 1992; 149:443-454.
7. Reid WGJ. The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes. International Journal of Psychogeriatrics 1992; 4:147-160.
8. Mann JJ, Kapur S. A dopaminergic hypothesis of depression. Clinical Neuropharmacology 1995; 18:557-65.
9. Austin MP, Mitchell P. The anatomy of melancholia: does frontal-subcortical pathophysiology underpin its psychomotor and cognitive manifestations? Psychological Medicine 1995; 25.665-672.
10. Hickie I. Issues in classification: III. Utilizing behavioural constructs in melancholia research. In: Parker G, Hadzi-Paviovic D. eds. Melancholia: a disorder of movement and mood. New York: Cambridge University Press. 1996:38-56.
11. Lloyd A, Dixon G, Huang XF et al. Molecular biology and the major psychoses. Australian and New Zealand Journal of Psychiatry 1997; 31:12-16.
12. Halliday GM, Li YW, Blumbergs PC et al. Neuropathology of immunohistochemically-identified neurons in Parkinson's disease. Annals of Neurology 1990, 27:373-385.
13. Dolan RJ, Grasby PM. Exploring the functional role of monoaminergic neurotransmission: a method for exploring neurotransmitter dysfunction in psychiatric disorders. British Journal of Psychiatry 1994; 164:575-580.
14. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. In: Uylings HBM, Van Eden CG, DeBruin JPC, Corner MA, Feenstra MGP, eds. Progress in brain research. Baltimore: Elsevier Science Publishers, 1990:119-145.
15. Joel D, Weiner I. The organisation of the basal gangliathalamocortical circuits open interconnected rather than closed segregated. Neuroscience 1994; 63:363-379.
16. Mayberg HS, Neuroimaging studies of depression in neurologic disease. In Starkstein SE, Robinson RG, eds. Depression in neurologic disease. Baltimore: Johns Hopkins University Press. 1993:186-216.
17. Krishan KRR. Neuroanatomic subtrates of depression in the elderly. Journal of Geriatric Psychiatry and Neurology 1993, 6:39-58.
18. Coffey CE, Wilkinson WE, Weiner RD et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Archives of General Psychiatry 1993; 50:7-16.
19. Krishnan KRR, Goli V, Ellinwood EH, France RD, Blazer DG, Nemerodd CB. Leukoencephalopathy in patients diagnosed as major depressive. Biological Psychiatry 1988; 23:519-522.
20. Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly. Journal of Neuropsychiatry and Clinical Neuroscience 1990; 147:187-189.
21. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B. Subcortical hyperintensities on magnetic resonance Imaging: clinical correlates and prognostic significance in patients with severe depression. Biological Psychiatry 1995; 37:151-160.
22. Krishnan KRR, McDonald WM, Localona PR et al. Magnetic resonance imaging of the caudate nuclei in depression: preliminary observations. Archives of General Psychiatry 1992; 49:553-557.
23. Husain MM, McDonald WM, Doraiswamy PM. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Research 1991; 40:95-99.
24. Dolan RJ, Bench CJ, Liddle PF et al. Dorsolateral prefrontal cortex dysfunction in the major psychoses: symptom or disease specificity? Journal of Neurology, Neurosurgery and Psychiatry 1993; 56:1290-1294.
25. Bench CJ, Friston KJ, Brown RG, Frackowiak RSJ, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychological Medicine 1993; 23:579-590.
26. Drevets WC, Videen TO, Price JL, Preskom SH, Carmichael T, Raichie ME. A functional anatomical study of unipolar depression. Journal of Neuroscience 1992; 12:3628-3641.
27. Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M. Reduction of cerebral blood flow in older depressed patients. Archives of General Psychiatry 1994; 51:677-686.
28. Robinson RG, Starkstein SE, Price TR. Post stroke depression and lesion location. Stroke 1988; 19:125-126.
29. Seeman P, Van Tol HHM. Dopamine receptor pharmacology. Trends in Pharmacological Sciences 1994; 15:264-270.
30. Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends in Pharmacological Sciences 1995; 16:270-275
31. Shaikh S, Collier D, Kerwin RW, Pilowsky LS, Gill M, Xu WM, Thomion A. Dopamine D4 receptor subtypes and response to clozapine. Lancet 1993; 341:116.
32. Meador-Woodruff JH. Neuroanatomy of dopamine receptor gene expression. Potential substrates for neuropsychiatric illness. Clinical Neuropharmacology 1995; 18:14-24.
33. Drago J Gerfen CR, Lachowicz JE et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:12564-12568.
34. 2 receptors. Nature 1995; 377:424-428.
35. Bermanzohn PC, Siris SG, Akinesia. A syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia Comprehensive Psychiatry 1992; 33:221-232
36. Carroll BJ. Psychopathology and neurobiology of manic-depressive disorders. In : Carroll BJ, Barren JE, eds. Psychopathology and the brain. New York: Raven Press. 1991.